| AKTX Stock | | | USD 1.21 0.09 8.04% |
Akari Therapeutics financial indicator trend analysis is way more than just evaluating Akari Therapeutics PLC prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Akari Therapeutics PLC is a good investment. Please check the relationship between Akari Therapeutics Income Before Tax and its Ebitda accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Akari Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
Income Before Tax vs Ebitda
Income Before Tax vs Ebitda Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Akari Therapeutics PLC Income Before Tax account and
Ebitda. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Akari Therapeutics' Income Before Tax and Ebitda is 0.93. Overlapping area represents the amount of variation of Income Before Tax that can explain the historical movement of Ebitda in the same time period over historical financial statements of Akari Therapeutics PLC, assuming nothing else is changed. The correlation between historical values of Akari Therapeutics' Income Before Tax and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Before Tax of Akari Therapeutics PLC are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Income Before Tax i.e., Akari Therapeutics' Income Before Tax and Ebitda go up and down completely randomly.
Correlation Coefficient | 0.93 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Akari Therapeutics income statement and is an important metric when analyzing Akari Therapeutics PLC profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.
Ebitda
Most indicators from Akari Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Akari Therapeutics PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Akari Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
Selling General Administrative is likely to drop to about 7.6
M in 2024.
Tax Provision is likely to drop to about (3
M) in 2024
Akari Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Akari Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Akari Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Akari Stock Analysis
When running Akari Therapeutics' price analysis, check to
measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.